Heinrichs S C, Joppa M, Lapsansky J, Jeske K, Nelson R, De Souza E
Neurocrine Biosciences, Inc., 10555 Science Center Drive, San Diego, CA 92121, USA.
Physiol Behav. 2001;74(1-2):5-13. doi: 10.1016/s0031-9384(01)00421-8.
Acute administration of corticotropin-releasing factor (CRF) results in anorexic and sympathomimetic effects that suggest efficacy in chronic models of energy balance. The present studies employed a broad spectrum energy balance indices in lean and genetically obese Zucker rats in order to fully characterize the pharmacological efficacy of CRF and a CRF binding protein (CRF-BP) ligand inhibitor, CRF(6-33), which is thought to liberate CRF from CRF-BP. Acute administration of CRF(6-33) significantly increased CRF(2) receptor density by 10% within the ventromedial hypothalamic (VMH) nucleus of Zucker lean rats and decreased density by 10% in Zucker obese rats. A single infusion of CRF(6-33) increased nonshivering thermogenesis by 25-30% as measured by proton conductance in brown adipose tissue of both lean and obese rats. Chronic CRF(6-33) infusion suppressed body weight gain and elevated core temperature irrespective of genotype while increasing motor activity in obese rats without altering heart rate or blood pressure. Taken together, these results document strain-dependent, long-term effects of a CRF-BP ligand inhibitor on a select subset of physiological and behavioral measures of increased energy expenditure.
急性给予促肾上腺皮质激素释放因子(CRF)会产生厌食和拟交感神经作用,这表明其在能量平衡慢性模型中具有疗效。本研究在瘦型和遗传性肥胖的 Zucker 大鼠中采用了广泛的能量平衡指标,以全面表征 CRF 和一种 CRF 结合蛋白(CRF-BP)配体抑制剂 CRF(6-33)的药理疗效,CRF(6-33)被认为可从 CRF-BP 中释放出 CRF。急性给予 CRF(6-33)可使 Zucker 瘦鼠腹内侧下丘脑(VMH)核内的 CRF(2)受体密度显著增加 10%,而使 Zucker 肥胖大鼠的受体密度降低 10%。单次注射 CRF(6-33)可使瘦鼠和肥胖大鼠棕色脂肪组织中的质子传导率所测得的非寒战产热增加 25% - 30%。长期输注 CRF(6-33)可抑制体重增加并提高核心体温,而与基因型无关,同时增加肥胖大鼠的运动活动,但不改变心率或血压。综上所述,这些结果证明了 CRF-BP 配体抑制剂对能量消耗增加的特定生理和行为指标具有品系依赖性的长期影响。